Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXRα Activity and a Favorable Window in Nonhuman Primates-Reference-Cited by-同舟云学术

Pharmacological Characterization of a Novel Liver X Receptor Agonist with Partial LXRα Activity and a Favorable Window in Nonhuman Primates

Published:2014-12-02 Issue:2 Volume:352 Page:305-314
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kirchgessner Todd G.,Martin Richard,Sleph Paul,Grimm Denise,Liu Xiaoqin,Lupisella John,Smalley James,Narayanan Rangaraj,Xie Yinong,Ostrowski Jacek,Cantor Glenn H.,Mohan Raju,Kick Ellen

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. A Novel Principle for Partial Agonism of Liver X Receptor Ligands

2. Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE

3. Critical tables for calculating the cholesterol saturation of native bile;Carey;J Lipid Res,1978

4. Regulation of cholesterol 7α-hydroxylase gene ( CYP7A1 ) transcription by the liver orphan receptor (LXRα)

5. Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver X Receptors (LXRs) in cancer-an Eagle’s view on molecular insights and therapeutic opportunities;Frontiers in Cell and Developmental Biology;2024-03-14

2. Identification of Novel Compounds Targeting the Liver X Receptor (LXR): in-silico studies, screening, molecular docking, and chemico-pharmacokinetic analysis;2023-12-06

3. 17β-ESTRADIOL REGULATES ADENOSINE TRIPHOSPHATE-BINDING CASSETTE TRANSPORTERS A1 EXPRESSION VIA ESTROGEN RECEPTOR Α TO INCREASE MACROPHAGE CHOLESTEROL EFFLUX;J PHYSIOL PHARMACOL;2023

4. Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review;Frontiers in Molecular Biosciences;2023-03-02

5. Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discovery;Clinical Science;2022-12